Assessment of Vitamin D Levels in Children Attending Outpatient Clinics of Johns Hopkins Aramco Healthcare, Saudi Arabia

Authors

  • Weam Moahmmed Women and child dept. Johns Hopkins Aramco Healthcare, southern area, KSA.
  • Kamal Deyab Women and child dept. Johns Hopkins Aramco Healthcare, southern area, KSA.
  • Al Habib Mohammed Primary care Dept. Johns Hopkins Aramco Healthcare, southern area, KSA.
  • Fatimah Al Salman Public health specialist, medical dept. Johns Hopkins Aramco Healthcare, southern area, KSA.
  • Gehad Mohamed Women and child dept. Johns Hopkins Aramco Healthcare, southern area, KSA.
  • Taha Ibrahim Yousif Women and child dept. Johns Hopkins Aramco Healthcare, southern area, KSA.

DOI:

https://doi.org/10.54293/smhj.v6i2.200

Keywords:

Vitamin D, Saudi Arabia

Abstract

Abstract


Background: Vitamin D deficiency is a common public health concern worldwide. Various guidelines exist for defining normal levels, testing and supplementation, with no consensus. This study aimed to assess vitamin D levels in children aged under 14 years attending our pediatric clinics in 2024, to review testing practices, and to compare these with existing guidelines.
Methods: Data on all 25-hydroxyvitamin D (25-OH Vit D) test results for children attending our primary care clinics during 2024 were collected electronically and analysed using SPSS.
Results: A total of 1448 25-OH Vit D tests were performed for 1346 patients; 55% were female. Ages ranged from 10 months to 14 years. Average levels of 25-OH Vit D. were 44.3 ng/mL (<2 years), 28 ng/mL (2–5 years), and 17.4 ng/mL (>5 years). Levels were higher in males than in females.  Vitamin D deficiency (<20 ng/mL) was present in 57% of patients, including 108 (7%) with severe deficiency (<10 ng/mL). 40% had normal levels (20–50 ng/mL). 36 tests from 31 patients (3%) showed values >50 ng/mL.  High levels were reported mostly in children younger than 2 years (65%). No patient had clinical features of vitamin D toxicity. 
Discussion: Vitamin D deficiency is prevalent in Saudi Arabia, as reported in national and global studies. The current variation in practice underscores the need to develop guidelines tailored to Saudi Arabia's unique cultural context.
Conclusions: We recommend universal vitamin D supplementation for all children under 14 years, restricting testing to high-risk groups, and adopting a clear protocol for retesting.

Author Biographies

Weam Moahmmed, Women and child dept. Johns Hopkins Aramco Healthcare, southern area, KSA.

Pediatrics Department, Johns Hopkins Aramco Healthcare

Kamal Deyab, Women and child dept. Johns Hopkins Aramco Healthcare, southern area, KSA.

Consultant pediatrican, Johns Hopkins Aramco Healthcare, Saudi Arabia

Al Habib Mohammed, Primary care Dept. Johns Hopkins Aramco Healthcare, southern area, KSA.

Johns Hopkins Aramco healthcare

Fatimah Al Salman, Public health specialist, medical dept. Johns Hopkins Aramco Healthcare, southern area, KSA.

Johns Hopkins Aramco Healthcare

Gehad Mohamed, Women and child dept. Johns Hopkins Aramco Healthcare, southern area, KSA.

Specialist in Obstetrics and Gynecology, Johns Hopkins Aramco Healthcare, Saudi Arabia

Downloads

Published

2026-06-01

How to Cite

1.
Mohammed W, Deyab K, Mohammed AH, Al Salman F, Mohamed G, Yousif TI. Assessment of Vitamin D Levels in Children Attending Outpatient Clinics of Johns Hopkins Aramco Healthcare, Saudi Arabia. SMHJ [Internet]. 2026 Jun. 1 [cited 2026 Jun. 1];6(2):238-47. Available from: https://www.smh-j.com/smhj/article/view/200

Issue

Section

Original Articles